Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Nagata is concerned that some people taking GLP-1s might fixate on weight loss at any cost
Its best to discuss semaglutide usage with a healthcare professional to start a tailored treatment plan
This data illustrates the rapid change: just 23 years prior, virtually no large employers covered GLP-1 weight-loss treatments
Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care
The closest thing WIRED got to an answer on patient numbers was from Hims chief medical officer Pat Carroll: Since launching a couple of months ago, weve done thousands of visits, he says
Am J Physiol Endocrinol Metab 2004
US$ 23.61
US$ 23.90
US$ 24.94
